Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, March 9, 2026…